You have 9 free searches left this month | for more free features.

City

Beijing (2)

Changsha (1)

Chengdu (1)

Fuzhou (1)

Jinan (1)

Shanghai (1)

Zhengzhou (1)

Condition

Brain Metastases (1)

Lymphoma, B-Cell (1)

Non-Small Cell Lung Cancer With EGFR Mutation (1)

Overall Status

Recruiting (2)

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Medolution Ltd. (2)

Collaborator

Intervention

keynatinib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

keynatinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma, B-Cell Trial in Beijing, Shanghai, Chengdu (Keynatinib)

Recruiting

Lymphoma, B-Cell

Keynatinib

Beijing, Beijing, China
+3 more

Apr 17, 2022

NSCLC With EGFR Mutation, Brain Metastases Trial in China (Keynatinib)

Recruiting

Non-Small Cell Lung Cancer With EGFR Mutation
Brain Metastases

Keynatinib

Beijing, Beijing, China
+4 more

Apr 17, 2022